Latest Share Chat

Physiomics secures follow-on contract from Merck KgaA

Fri, 14th May 2021 09:27

(Alliance News) - Physiomics PLC on Friday said it has been awarded a further contract by existing client Merck KGaA that it expects to be completed over the next two to three months.

The Oxford, England-based tumor technology firm said the contract follows on from and is additional to the initial tranche of projects with Merck announced in December 2020, with a value of GBP270,000, intended to be completed in the first six to eight months of 2021.

Physiomics shares were trading 11% higher in London on Friday morning at 6.65 pence each.

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Related Shares

More News

3 May 2024 14:34

IN BRIEF: Physiomics warns large contracts taken longer than expected

Physiomics PLC - Milton Park, England-based data science company, focused on new therapeutics and personalised medicine solutions - Warns several larg...

3 May 2024 11:21

Physiomics lowers forecasts amid contract delays

(Sharecast News) - Therapeutics and medicine-focussed mathematical modelling and data science company Physiomics said in an update on Friday that, des...

3 May 2024 10:52

AIM WINNERS & LOSERS: Fletcher King optimistic; Angle in Astra deal

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

18 Mar 2024 11:57

IN BRIEF: Physiomics celebrates "substantial" contract with old client

Physiomics PLC - mathematical modelling company that supports oncology drug development - Receives a "substantial" new contract by an existing "large ...

18 Mar 2024 09:43

Physiomics secures 'substantial new contract' with existing pharma client

(Sharecast News) - Mathematical modelling and data science company Physiomics has been awarded "a substantial new contract" by an existing large pharm...